Widening CNS Access Will Shape Long-term Market Opportunity

Shared on30 Apr 25
Fair value Increased 3.72%

Shared on23 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on17 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on09 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on02 Apr 25
Fair value Increased 0.60%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on26 Mar 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on19 Mar 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on11 Mar 25
Fair value Decreased 9.13%

AnalystConsensusTarget has increased revenue growth from 4.1% to 4.6%, increased profit margin from 8.0% to 10.1% and decreased future PE multiple from 49.1x to 35.1x.